The long-term objectives of this proposal are to identify and to study a locus that is required for normal murine development in utero and for normal hepatic function after birth. This locus is identified by an insertional mutation due to a transgene integration; homozygous transgenic mice are runted at birth, feed poorly, and usually die during the first two days of life with a severely necrotic liver. The morphology of the hepatic injury appears similar to that seen in toxic liver injury or fulminant hepatitis. The affected locus is called ple, for perinatal lethality. The transgene has been mapped to a region of mouse chromosome 15 whose genetic organization has been conserved during evolution, suggesting the likelihood that there is a human homolog of the ple locus. The insertion site of the transgene has been cloned, which will facilitate the characterization of the gene(s) whose expression is affected by the transgene integration.
The specific aims of the proposal are to use well-proven strategies for the identification of transcribed genes in cloned genomic DNA sequences to obtain a full-length cDNA to the locus (or loci) that are disrupted by the transgene. Since there is evidence (by cross-hybridization) that there are related murine loci and the suggestion (by conservation of synteny) that there is a human homolog, these genes will also be pursued. These will then be characterized by biochemical and expression analysis in order to gain understanding of their role in normal murine development and hepatic metabolism. Because the region of chromosome 15 to which the ple locus maps contains a number of mouse mutations, and because this region has been conserved in humans, it is furthermore a specific aim to generate a detailed physical and genetic map of this region using pulsed-field gel electrophoresis and interspecific recombination mapping analysis, respectively. Additionally, it should be feasible to use crosses of ple with recombinant inbred mouse strains to map loci which influence expression of the ple phenotype. Based on genetic and physical analysis, it is possible that the disrupted locus is a member of the type II cytokeratin gene family. While this class of intermediate filaments has been studied extensively biochemically, no specific mutations in a cytokeratin have been identified, and their role in cellular physiology is not well understood. If the ple insertional mutation proves to be a cytokeratin, it will serve as a valuable resource for the study of inter-mediate filament gene function. Finally, a number of abnormal phenotypes, some clearly due to spontaneous mutations that are unlinked to the transgene, have been identified in this transgenic line. This transgenic line may be genetically unstable and have an elevated mutation frequency. Since there is presently insufficient evidence to prove this hypothesis, it will be necessary to continue to characterize the morphology and heritable nature of the abnormal phenotypes.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD029028-03
Application #
2201541
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1992-05-01
Project End
1996-04-30
Budget Start
1994-05-01
Budget End
1995-04-30
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Rao, Cherie; Foernzler, Dorothee; Loftus, Stacie K et al. (2003) A defect in a novel ADAMTS family member is the cause of the belted white-spotting mutation. Development 130:4665-72
Schon, M P; Arya, A; Murphy, E A et al. (1999) Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol 162:6641-9
Mount, D B; Baekgaard, A; Hall, A E et al. (1999) Isoforms of the Na-K-2Cl cotransporter in murine TAL I. Molecular characterization and intrarenal localization. Am J Physiol 276:F347-58
Green, R M; Lo, K; Sterritt, C et al. (1999) Cloning and functional expression of a mouse liver organic cation transporter. Hepatology 29:1556-62
Kvist, A P; Latvanlehto, A; Sund, M et al. (1999) Complete exon-intron organization and chromosomal location of the gene for mouse type XIII collagen (col13a1) and comparison with its human homologue. Matrix Biol 18:261-74
Dangond, F; Foerznler, D; Weremowicz, S et al. (1999) Cloning and expression of a murine histone deacetylase 3 (mHdac3) cDNA and mapping to a region of conserved synteny between murine chromosome 18 and human chromosome 5. Mol Cell Biol Res Commun 2:91-6
Donaldson, D D; Whitters, M J; Fitz, L J et al. (1998) The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 161:2317-24
Fitz, L J; Morris, J C; Towler, P et al. (1997) Characterization of murine Flt4 ligand/VEGF-C. Oncogene 15:613-8
Lopez-Nieto, C E; You, G; Bush, K T et al. (1997) Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney. J Biol Chem 272:6471-8
Skvorak, A B; Robertson, N G; Yin, Y et al. (1997) An ancient conserved gene expressed in the human inner ear: identification, expression analysis, and chromosomal mapping of human and mouse antiquitin (ATQ1). Genomics 46:191-9

Showing the most recent 10 out of 17 publications